Table 2.
Peak change in MBP (mmHg) over all doses of agonist | |||
---|---|---|---|
Treatment and AI dose | Anti-AI IgG titre | AI | AII |
Saline control (0 µg) | 0 | 25.5 ± 2.8 | 24.3 ± 1.6 |
PMD2850 (25 µg) | 55629 ± 14414 | 15.4 ± 1.7* | 22.1 ± 1.5 |
PMD3117 (10 µg) | 66121 ± 13264 | 13.3 ± 2.4* | 15.7 ± 3.0 |
PMD3117 (50 µg) | 67410 ± 7393 | 13.8 ± 2.8* | 19.0 ± 3.3 |
Significance probabilities (P) were adjusted for the multiple MBP comparisons by Dunnett's method,
P < 0.05 vs. the saline control treatment. Values are mean ± SEM, n = 6.